Biopharmaceutical Providers Draw Interest from Investors Like Armistice Capital
Dedicated to researching and producing innovative therapies to treat a variety of conditions, the biopharmaceutical sector has experienced notable growth in recent years — particularly in the U.S. Between 2015 and 2020, U.S. companies were…